Physician

Adam Charles Frank, M.D., PH.D.

According to 2025 Medicare claims, Adam Frank, M.D., PH.D. (NPI: 1568995520) practices psychiatry in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is USC CARE MEDICAL GROUP, INC (NPI: 1902846306; TIN: 954540991) and primary practice location at 90033-5310. Frank is affiliated with the Lore Health ACO (ACO ID: A5192), participating under the MSSP model.

Frank's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 14 traditional Medicare patients, billed 133 HCPCS/CPT codes, and received $10,041 in Medicare payments. Part D data shows 166 prescription claims across 13 beneficiaries totaling $3,837 in drug costs, led by Bupropion Xl (Bupropion Hcl). Open Payments data shows 9 records totaling $620. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,192 to $3,837. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$7.0K$14K2022 Medicare payment: $13,994 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $9,212 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $10,041 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202233130$13,994
202318104$9,212
202414133$10,041

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$16K$31K2019 Drug cost: $1,192 (USD; Tot_Drug_Cst)2020 Drug cost: $2,472 (USD; Tot_Drug_Cst)2021 Drug cost: $731 (USD; Tot_Drug_Cst)2022 Drug cost: $31,314 (USD; Tot_Drug_Cst)2023 Drug cost: $13,006 (USD; Tot_Drug_Cst)2024 Drug cost: $3,837 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20191340$1,192
2020N/R69$2,472
2021N/R14$731
202222205$31,314
202324172$13,006
202413166$3,837

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Part B summary data is connected for 2024, but public code-level payment amounts are not available, so a Top 5 by total payments cannot be shown.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bupropion XlBupropion Hcl161,440$816
Escitalopram OxalateEscitalopram Oxalate131,170$293
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine13390$274
Fluvoxamine MaleateFluvoxamine Maleate13390$91
LamotrigineLamotrigine11690$85

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$376Abbott Laboratories
Research PaymentsReported research-related payment or transfer-of-value amount.7$244Abbott Laboratories
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Charles Frank, M.D., PH.D.?

Tedicare shows public-source Medicare data for Adam Charles Frank, M.D., PH.D. (NPI 1568995520), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Charles Frank, M.D., PH.D. have ACO affiliation data?

Adam Charles Frank, M.D., PH.D. is shown with ACO affiliation data for Lore Health ACO (MSSP, ACO ID A5192).

What billing organization is linked to Adam Charles Frank, M.D., PH.D.?

Adam Charles Frank, M.D., PH.D. is linked to USC CARE MEDICAL GROUP, INC (billing NPI 1902846306) in the available physician profile data.

Does Adam Charles Frank, M.D., PH.D. have Open Payments data?

Adam Charles Frank, M.D., PH.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.